198 related articles for article (PubMed ID: 27461849)
1. Dose-Dependent Suppression of Cytokine production from T cells by a Novel Phosphoinositide 3-Kinase Delta Inhibitor.
Way EE; Trevejo-Nunez G; Kane LP; Steiner BH; Puri KD; Kolls JK; Chen K
Sci Rep; 2016 Jul; 6():30384. PubMed ID: 27461849
[TBL] [Abstract][Full Text] [Related]
2. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
[TBL] [Abstract][Full Text] [Related]
3. Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases.
Chen S; Paveley R; Kraal L; Sritharan L; Stevens E; Dedi N; Shock A; Shaw S; Juarez M; Yeremenko N; Baeten D; Payne A
J Autoimmun; 2020 Jul; 111():102435. PubMed ID: 32360069
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of cytokine production by PI3Kdelta in human monocytes upon acute and chronic inflammatory conditions.
Molnarfi N; Brandt KJ; Gruaz L; Dayer JM; Burger D
Mol Immunol; 2008 Jul; 45(12):3419-27. PubMed ID: 18471882
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory potential of PI3Kδ and JAK inhibitors in asthma patients.
Southworth T; Plumb J; Gupta V; Pearson J; Ramis I; Lehner MD; Miralpeix M; Singh D
Respir Res; 2016 Oct; 17(1):124. PubMed ID: 27716212
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of PI3Kδ Enhances Poly I:C-Induced Antiviral Responses and Inhibits Replication of Human Metapneumovirus in Murine Lungs and Human Bronchial Epithelial Cells.
Fujita A; Kan-O K; Tonai K; Yamamoto N; Ogawa T; Fukuyama S; Nakanishi Y; Matsumoto K
Front Immunol; 2020; 11():432. PubMed ID: 32218789
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.
Suárez-Fueyo A; Rojas JM; Cariaga AE; García E; Steiner BH; Barber DF; Puri KD; Carrera AC
J Immunol; 2014 Jul; 193(2):544-54. PubMed ID: 24935930
[TBL] [Abstract][Full Text] [Related]
8. Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.
Rao VK; Webster S; Dalm VASH; Šedivá A; van Hagen PM; Holland S; Rosenzweig SD; Christ AD; Sloth B; Cabanski M; Joshi AD; de Buck S; Doucet J; Guerini D; Kalis C; Pylvaenaeinen I; Soldermann N; Kashyap A; Uzel G; Lenardo MJ; Patel DD; Lucas CL; Burkhart C
Blood; 2017 Nov; 130(21):2307-2316. PubMed ID: 28972011
[TBL] [Abstract][Full Text] [Related]
9. PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment.
Piddock RE; Loughran N; Marlein CR; Robinson SD; Edwards DR; Yu S; Pillinger GE; Zhou Z; Zaitseva L; Auger MJ; Rushworth SA; Bowles KM
Blood Cancer J; 2017 Mar; 7(3):e539. PubMed ID: 28282033
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110delta-dependent mechanism.
Farghaly HS; Blagbrough IS; Medina-Tato DA; Watson ML
Mol Pharmacol; 2008 May; 73(5):1530-7. PubMed ID: 18276774
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of PI3-Kinase catalytic isoforms p110γ and p110δ in mice enhances the IL-17/G-CSF axis and induces neutrophilia.
Bucher K; Schmitt F; Mothes B; Blumendeller C; Schäll D; Piekorz R; Hirsch E; Nürnberg B; Beer-Hammer S
Cell Commun Signal; 2017 Jul; 15(1):28. PubMed ID: 28724384
[TBL] [Abstract][Full Text] [Related]
12. PI3Kδ Forms Distinct Multiprotein Complexes at the TCR Signalosome in Naïve and Differentiated CD4
Luff DH; Wojdyla K; Oxley D; Chessa T; Hudson K; Hawkins PT; Stephens LR; Barry ST; Okkenhaug K
Front Immunol; 2021; 12():631271. PubMed ID: 33763075
[TBL] [Abstract][Full Text] [Related]
13. Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival.
Juss JK; Hayhoe RP; Owen CE; Bruce I; Walmsley SR; Cowburn AS; Kulkarni S; Boyle KB; Stephens L; Hawkins PT; Chilvers ER; Condliffe AM
PLoS One; 2012; 7(9):e45933. PubMed ID: 23029326
[TBL] [Abstract][Full Text] [Related]
14. PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation.
Haylock-Jacobs S; Comerford I; Bunting M; Kara E; Townley S; Klingler-Hoffmann M; Vanhaesebroeck B; Puri KD; McColl SR
J Autoimmun; 2011 May; 36(3-4):278-87. PubMed ID: 21396797
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB.
Cho ML; Ju JH; Kim KW; Moon YM; Lee SY; Min SY; Cho YG; Kim HS; Park KS; Yoon CH; Lee SH; Park SH; Kim HY
Immunol Lett; 2007 Jan; 108(1):88-96. PubMed ID: 17161467
[TBL] [Abstract][Full Text] [Related]
16. Effects of AS2541019, a novel selective PI3Kδ inhibitor, on antibody production and hamster to rat xenotransplantation.
Marui T; Fukahori H; Kawashima T; Ito M; Akamatsu M; Kaneko Y; Takahashi F; Imada S; Morokata T
Eur J Pharmacol; 2018 May; 826():179-186. PubMed ID: 29518396
[TBL] [Abstract][Full Text] [Related]
17. Phosphoinositide 3-Kinase P110δ-Signaling Is Critical for Microbiota-Activated IL-10 Production by B Cells that Regulate Intestinal Inflammation.
Oka A; Mishima Y; Liu B; Herzog JW; Steinbach EC; Kobayashi T; Plevy SE; Sartor RB
Cells; 2019 Sep; 8(10):. PubMed ID: 31546615
[TBL] [Abstract][Full Text] [Related]
18. Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K
Allen RA; Brookings DC; Powell MJ; Delgado J; Shuttleworth LK; Merriman M; Fahy IJ; Tewari R; Silva JP; Healy LJ; Davies GCG; Twomey B; Cutler RM; Kotian A; Crosby A; McCluskey G; Watt GF; Payne A
J Pharmacol Exp Ther; 2017 Jun; 361(3):429-440. PubMed ID: 28442583
[TBL] [Abstract][Full Text] [Related]
19. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide 3-Kinase δ Regulates Dectin-2 Signaling and the Generation of Th2 and Th17 Immunity.
Lee MJ; Yoshimoto E; Saijo S; Iwakura Y; Lin X; Katz HR; Kanaoka Y; Barrett NA
J Immunol; 2016 Jul; 197(1):278-87. PubMed ID: 27194783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
